Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.38 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.37 |
| ▸ | CPB2 | Q96IY4 | 5/20 | 0.36 |
| ▸ | CPB1 | P15086 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | ARG1 | P05089 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3794190 | 0.84 | GABRA1 (0.35) | — | |
| Ornithine SCHEMBL3801714 | 0.74 | GSR (0.39) | GSRSLC7A5CPB2CPB1ARG1 | |
| Ornithine SCHEMBL9998922 | 0.69 | MEN1 (0.38) | GSR | |
| SCHEMBL4636005 | 0.66 | GABRA1 (0.37) | — | |
| Ornithine SCHEMBL3443860 | 0.65 | GSR (0.78) | GSRCYP3A4ARG1 | |
| Ornithine Aketoglutarate SCHEMBL28452040 | 0.65 | GSR (0.78) | GSRCYP3A4ARG1 | |
| Ornithine Aketoglutarate SCHEMBL28086774 | 0.65 | GSR (0.78) | GSRCPB2ARG1 | |
| Ornithine SCHEMBL624782 | 0.65 | GSR (0.86) | GSRCPB2ARG1 | |
| D-Ornithine SCHEMBL43724 | 0.65 | — | — | |
| D-Ornithine SCHEMBL1537220 | 0.65 | GSR (0.86) | GSRCPB2ARG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110312877-A1 | ENGINEERED TUNABLE NANOPARTICLES FOR DELIVERY OF THERAPEUTICS, DIAGNOSTICS, AND EXPERIMENTAL COMPOUNDS AND RELATED COMPOSITIONS FOR THERAPEUTIC USE | APARNA BIOSCEIENCES (US) | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110312877-A1 | ENGINEERED TUNABLE NANOPARTICLES FOR DELIVERY OF THERAPEUTICS, DIAGNOSTICS, AND EXPERIMENTAL COMPOUNDS AND RELATED COMPOSITIONS FOR THERAPEUTIC USE | TLR3, CHIA, TSG101 | GSR 2747/4885SLC7A5 3132/4885CPB2 686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.